Development of a novel therapeutic suppressor of brain proinflammatory cytokine up-regulation that attenuates synaptic dysfunction and behavioral deficits
…, L Munoz, L Guo, LJ Van Eldik, DM Watterson
Index: Hu, Wenhui; Ralay Ranaivo, Hantamalala; Roy, Saktimayee M.; Behanna, Heather A.; Wing, Laura K.; Munoz, Lenka; Guo, Ling; Van Eldik, Linda J.; Watterson, D. Martin Bioorganic and Medicinal Chemistry Letters, 2007 , vol. 17, # 2 p. 414 - 418
Full Text: HTML
Citation Number: 68
Abstract
We report the development of a novel, aqueous-soluble, safe, small molecule, experimental therapeutic that suppresses injury-induced, proinflammatory cytokine increases in the brain, with resultant attenuation of synaptic protein biomarker loss and improvement in hippocampus-dependent behavioral deficits. A GMP production scheme for the active pharmaceutical ingredient, compound 17, is presented. The development and large-scale ...
Related Articles:
[Turck, A.; Ple, N.; Mojovic, L.; Queguiner, G. Bulletin de la Societe Chimique de France, 1993 , vol. 130, p. 488 - 492]
[Turck, A.; Ple, N.; Mojovic, L.; Queguiner, G. Bulletin de la Societe Chimique de France, 1993 , vol. 130, p. 488 - 492]
[de Araujo-Junior, Joao X.; Schmitt, Martine; Benderitter, Pascal; Bourguignon, Jean-Jacques Tetrahedron Letters, 2006 , vol. 47, # 34 p. 6125 - 6128]
[Turck, A.; Ple, N.; Mojovic, L.; Queguiner, G. Bulletin de la Societe Chimique de France, 1993 , vol. 130, p. 488 - 492]